PLANET LABS PBC (PL) Fundamental Analysis & Valuation

NYSE:PL • US72703X1063

Current stock price

37.7819 USD
-0.51 (-1.33%)
Last:

This PL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PL Profitability Analysis

1.1 Basic Checks

  • PL had negative earnings in the past year.
  • In the past year PL had a positive cash flow from operations.
  • PL had negative earnings in each of the past 5 years.
  • In the past 5 years PL reported 4 times negative operating cash flow.
PL Yearly Net Income VS EBIT VS OCF VS FCFPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 2026 0 100M -100M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -21.55%, PL is doing worse than 81.40% of the companies in the same industry.
  • PL has a Return On Equity of -131.01%. This is amonst the worse of the industry: PL underperforms 88.37% of its industry peers.
Industry RankSector Rank
ROA -21.55%
ROE -131.01%
ROIC N/A
ROA(3y)-20.33%
ROA(5y)-19.84%
ROE(3y)-62.02%
ROE(5y)-47.06%
ROIC(3y)N/A
ROIC(5y)N/A
PL Yearly ROA, ROE, ROICPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

1.3 Margins

  • PL's Gross Margin of 56.05% is fine compared to the rest of the industry. PL outperforms 72.09% of its industry peers.
  • PL's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for PL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.49%
GM growth 5Y19.72%
PL Yearly Profit, Operating, Gross MarginsPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 2026 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. PL Health Analysis

2.1 Basic Checks

  • PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PL has more shares outstanding than it did 1 year ago.
  • PL has more shares outstanding than it did 5 years ago.
  • PL has a worse debt/assets ratio than last year.
PL Yearly Shares OutstandingPL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
PL Yearly Total Debt VS Total AssetsPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B

2.2 Solvency

  • PL has an Altman-Z score of 6.85. This indicates that PL is financially healthy and has little risk of bankruptcy at the moment.
  • PL has a Altman-Z score of 6.85. This is amongst the best in the industry. PL outperforms 88.37% of its industry peers.
  • PL has a debt to FCF ratio of 8.69. This is a slightly negative value and a sign of low solvency as PL would need 8.69 years to pay back of all of its debts.
  • PL has a Debt to FCF ratio (8.69) which is in line with its industry peers.
  • PL has a Debt/Equity ratio of 2.37. This is a high value indicating a heavy dependency on external financing.
  • PL's Debt to Equity ratio of 2.37 is on the low side compared to the rest of the industry. PL is outperformed by 84.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.37
Debt/FCF 8.69
Altman-Z 6.85
ROIC/WACCN/A
WACC8.86%
PL Yearly LT Debt VS Equity VS FCFPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 2026 0 200M 400M 600M

2.3 Liquidity

  • PL has a Current Ratio of 1.65. This is a normal value and indicates that PL is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.65, PL perfoms like the industry average, outperforming 54.65% of the companies in the same industry.
  • PL has a Quick Ratio of 1.64. This is a normal value and indicates that PL is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.64, PL perfoms like the industry average, outperforming 56.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.64
PL Yearly Current Assets VS Current LiabilitesPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 85.71% over the past year.
  • PL shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.94%.
  • PL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.14% yearly.
EPS 1Y (TTM)85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y17.17%
Revenue growth 5Y22.14%
Sales Q2Q%41.05%

3.2 Future

  • PL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 113.45% yearly.
  • Based on estimates for the next years, PL will show a very strong growth in Revenue. The Revenue will grow by 33.64% on average per year.
EPS Next Y-181.05%
EPS Next 2Y66.25%
EPS Next 3Y113.45%
EPS Next 5YN/A
Revenue Next Year42.04%
Revenue Next 2Y36.01%
Revenue Next 3Y33.64%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PL Yearly Revenue VS EstimatesPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
PL Yearly EPS VS EstimatesPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. PL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PL Price Earnings VS Forward Price EarningsPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PL indicates a slightly more expensive valuation: PL is more expensive than 66.28% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 254.37
EV/EBITDA N/A
PL Per share dataPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • PL's earnings are expected to grow with 113.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.25%
EPS Next 3Y113.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PL Dividend Analysis

5.1 Amount

  • No dividends for PL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PL Fundamentals: All Metrics, Ratios and Statistics

PLANET LABS PBC

NYSE:PL (4/24/2026, 9:44:07 AM)

37.7819

-0.51 (-1.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)03-19
Earnings (Next)06-02
Inst Owners72.67%
Inst Owner Change0.01%
Ins Owners1.64%
Ins Owner Change-3.21%
Market Cap13.08B
Revenue(TTM)307.73M
Net Income(TTM)-246.86M
Analysts81.05
Price Target35.6 (-5.77%)
Short Float %12.98%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)100%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)82.59%
Min EPS beat(4)30.37%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)24.82%
EPS beat(12)11
Avg EPS beat(12)23.28%
EPS beat(16)14
Avg EPS beat(16)19.63%
Revenue beat(2)2
Avg Revenue beat(2)8.46%
Min Revenue beat(2)7.34%
Max Revenue beat(2)9.58%
Revenue beat(4)4
Avg Revenue beat(4)7.14%
Min Revenue beat(4)3.27%
Max Revenue beat(4)9.58%
Revenue beat(8)4
Avg Revenue beat(8)1.64%
Revenue beat(12)4
Avg Revenue beat(12)0.14%
Revenue beat(16)6
Avg Revenue beat(16)0.72%
PT rev (1m)32%
PT rev (3m)85.34%
EPS NQ rev (1m)-16.11%
EPS NQ rev (3m)-16.11%
EPS NY rev (1m)-45.32%
EPS NY rev (3m)-45.32%
Revenue NQ rev (1m)6.28%
Revenue NQ rev (3m)6.28%
Revenue NY rev (1m)11.99%
Revenue NY rev (3m)12.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 42.5
P/FCF 254.37
P/OCF 97.34
P/B 69.41
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.15
FCFY0.39%
OCF(TTM)0.39
OCFY1.03%
SpS0.89
BVpS0.54
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -21.55%
ROE -131.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.05%
FCFM 16.71%
ROA(3y)-20.33%
ROA(5y)-19.84%
ROE(3y)-62.02%
ROE(5y)-47.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.49%
GM growth 5Y19.72%
F-Score2
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 2.37
Debt/FCF 8.69
Debt/EBITDA N/A
Cap/Depr 198.32%
Cap/Sales 26.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.64
Altman-Z 6.85
F-Score2
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)135.52%
Cap/Depr(5y)93.83%
Cap/Sales(3y)22.81%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-181.05%
EPS Next 2Y66.25%
EPS Next 3Y113.45%
EPS Next 5YN/A
Revenue 1Y (TTM)25.94%
Revenue growth 3Y17.17%
Revenue growth 5Y22.14%
Sales Q2Q%41.05%
Revenue Next Year42.04%
Revenue Next 2Y36.01%
Revenue Next 3Y33.64%
Revenue Next 5YN/A
EBIT growth 1Y9.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.95%
EBIT Next 3Y70.68%
EBIT Next 5YN/A
FCF growth 1Y174.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1034.76%
OCF growth 3YN/A
OCF growth 5YN/A

PLANET LABS PBC / PL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PLANET LABS PBC?

ChartMill assigns a fundamental rating of 3 / 10 to PL.


Can you provide the valuation status for PLANET LABS PBC?

ChartMill assigns a valuation rating of 1 / 10 to PLANET LABS PBC (PL). This can be considered as Overvalued.


What is the profitability of PL stock?

PLANET LABS PBC (PL) has a profitability rating of 1 / 10.


What is the financial health of PLANET LABS PBC (PL) stock?

The financial health rating of PLANET LABS PBC (PL) is 3 / 10.